Zhinan Xia
- Immunology top 10%
- Immunotherapy and Immune Responses 3
-
- CAR-T cell therapy research 2
-
- Renal and related cancers 3
-
- Ferroptosis and cancer prognosis 5
- Renal cell carcinoma treatment 4
-
- Cancer Genomics and Diagnostics 3
-
- Monoclonal and Polyclonal Antibodies Research 3
-
- Advanced Proteomics Techniques and Applications 2
- Co-authors
- Lee M. NadlerKaren S. AndersonJoachim L. SchultzeMichael S. von Bergwelt‐BaildonBritta MaeckerMarcus O. ButlerKai W. WucherpfennigRobert H. Vonderheide
- Cited by
- ImmunologyOncologyMolecular Biology
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Zhinan Xia
22 papers receiving 520 citations
Peers
Comparison fields: 5 of 73
- Immunology 257
- Oncology 155
- Molecular Biology 177
- Hepatology 20
- Hematology 24
Countries citing papers authored by Zhinan Xia
This map shows the geographic impact of Zhinan Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhinan Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhinan Xia more than expected).
Fields of papers citing papers by Zhinan Xia
This network shows the impact of papers produced by Zhinan Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhinan Xia. The network helps show where Zhinan Xia may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhinan Xia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 5 | |
| 4 | 2023 | 7 | |
| 5 | 2023 | 16 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 3 | |
| 8 | 2022 | 2 | |
| 9 | 2022 | 6 | |
| 10 | 2021 | 12 | |
| 11 | 2019 | 1 | |
| 12 | 2015 | 59 | |
| 13 | 2013 | 36 | |
| 14 | 2008 | 29 | |
| 15 | 2006 | 7 | |
| 16 | 2005 | 28 | |
| 17 | 2005 | 54 | |
| 18 | 2004 | 83 | |
| 19 | 2004 | 5 | |
| 20 | 2002 | 158 |
About Zhinan Xia
Zhinan Xia is a scholar working on Immunology, Cancer Research and Oncology, having authored 22 papers that have together received 526 indexed citations. Recurring topics across this work include Ferroptosis and cancer prognosis (5 papers), Renal cell carcinoma treatment (4 papers), Renal and related cancers (3 papers), Immunotherapy and Immune Responses (3 papers), Cancer Genomics and Diagnostics (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Advanced Proteomics Techniques and Applications (2 papers). The work is most often cited by research in Immunology (257 citations), Oncology (155 citations) and Molecular Biology (177 citations). Zhinan Xia has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Lee M. Nadler, Karen S. Anderson, Joachim L. Schultze, Michael S. von Bergwelt‐Baildon, Britta Maecker, Marcus O. Butler, Kai W. Wucherpfennig, Robert H. Vonderheide, Naoto Hirano and Zhongpeng Dai. Their work appears in journals such as Blood, Cancer Research and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.